TrialThe Lancet. Oncology2010

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study.

Jedd D Wolchok et al.PubMed ↗Publisher ↗

No numbers read from the abstract.